BSX

Boston Scientific (BSX) is at a 52-week high, but can investors hope for more gains in the future? We take...

Acquisition to expand cardiovascular portfolio with complementary and differentiated calcium modification platform, furthering company's strategy to address coronary and peripheral...

Boston Scientific successfully continues its expansion of operations across different geographies outside the United States.

In the most recent trading session, Boston Scientific (BSX) closed at $91.29, indicating a +0.66% shift from the previous trading...

Here is how Boston Scientific (BSX) and Aclarion, Inc. (ACON) have performed compared to their sector so far this year.

Five non-technology high-flyers of 2024 have the potential to fly higher in the short term. These are: CMG, IBKR, KKR,...

Investors continue to be optimistic about BSX, courtesy of its international expansion efforts and WATCHMAN's performance.

Boston Scientific (BSX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients...

In the closing of the recent trading day, Boston Scientific (BSX) stood at $89.68, denoting a -1.08% change from the...